PEPG | PepGen Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	9.06 - 9.71
52 Week Range	3.72 - 19.30
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	60,228
Average Volume	176,267
Shares Outstanding	32,589,703
Market Cap	297,218,091
Sector	Healthcare
Industry	Biotechnology
IPO Date	2022-05-06

Valuation
Profitability
Growth
Health
P/E Ratio	-2.76
Forward P/E Ratio	-3.10
EPS	-3.31
1YR Price Target	20.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	72
Country	USA
Website	PEPG

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.

PEPG's peers: ACIU, ANTX, PMCB, CADL, ELYM, CMPX, GHRS, GNTA, HCWB, IOBT, MGNX, MNOV, MNPR, MOLN, OLMA, OMGA, ORIC, PHVS, PMVP, PRAX, PRLD, PSTX, RAPT, RLYB, SEER, SLGL, TARS, THTX, TRDA, URGN, VIGL, HLVX, MLYS, IPSC, EWTX, CCCC, CGEM, TYRA, PRTC, QNCX, VANI, NAMS, KA

*Chart delayed

Analyzing fundamentals for PEPG we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see PEPG Fundamentals page.

Watching at PEPG technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PEPG Technicals page.